Advanced Oncotherapy (AVO) – Video and update on progress at Harley Street

Advanced Oncotherapy (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, announces the release of a short video providing an update on the facility at Harley Street and progress made on site. The video features Deconstruct (UK) Limited, principal contractor to the project, and highlights its role in the demolition, excavation and rebuild at […]

Advanced Oncotherapy (AVO) – Harley Street construction update

Advanced Oncotherapy (AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that excavation work at its flagship Harley Street site is progressing well and on time. Work has been completed on multiple stages of site work and demolition activity, with groundworks and piling, the longest stage in the excavation and build process […]

Advanced Oncotherapy (AVO) – Update on Bracknor financing

Advanced Oncotherapy (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that further to the notification on 22 February 2017, the Company has drawn down the second tranche of £1.3 million (less 5%, in accordance with terms for receipt of 95% of nominal value of each tranche). Proceeds will continue to […]

Advanced Oncotherapy (AVO) – Update on financing and Harley Street building work update

Advanced Oncotherapy (AVO), the developer of next generation proton therapy systems for cancer treatment, announces that further to the financing agreement with Bracknor announced on 22 February 2017, the first tranche has been drawn down by the Company and the initial funds of £1.3 million received (less 5%, in accordance with terms for receipt of […]

Advanced Oncotherapy (AVO) – Harley Street planning permission granted

Harley Street planning permission granted   Advanced Oncotherapy (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that at a meeting held yesterday at Westminster City Council, planning permission for the Harley Street site was granted. Commenting, Dr. Michael Sinclair, Executive Chairman and CEO of Advanced Oncotherapy, said: “The Harley Street Proton […]

Advanced Oncotherapy (AVO) – Update on Harley Street

Advanced Oncotherapy plc (AVO) notes that a number of shareholders have raised concerns that a planning application submitted by Howard de Walden Estates Limited for 141-143 Harley Street was withdrawn in January 2016 and that this will have an impact on the Company’s progress.  Howard de Walden Estates and Advanced Oncotherapy have confirmed that the […]